**Acknowledgements**

The author acknowledges the invaluable information obtained from his previous published works in Refs. [1–3], during the preparation of this book chapter.

[8] Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: A meta-analysis. The Pediatric Infectious Disease Journal. 2008;**27**(4):302-308.

Biomarkers of Common Childhood Renal Diseases http://dx.doi.org/10.5772/intechopen.74016 135

[9] Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatric Clinics of North

[10] Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;**341**:515-518.

[11] Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. Journal of Clinical Endocrinology and Metabolism. 1994;**79**:1065-1608.

[12] Meisner M, Tsachaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the

[13] Balci C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoğlu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Critical Care. 2003;**7**:85-90. DOI:

[14] Gürgöze MK, Akarsu S, Yilmaz E, Gödekmerdan A, Akça Z, Çiftçi I, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatric Nephrology.

[15] Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatric Nephrology. 2002;**17**:409-412.

[16] Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacomuzzi F, et al. Procalcitonin: A marker of severity of acute pyelonephritis among children. Pediatrics. 2004;**114**:e249-e254.

[17] Leroy S, Adamsbaum C, Marc E, Moulin F, Raymond J, Gendrel D, et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection.

[18] Sun HL, Wu KH, Chen SM, Chao YH, Ku MS, Hung TW, et al. Role of procalcitonin in predicting dilating vesicoureteral reflux in young children hospitalized with a first febrile urinary tract infection. The Pediatric Infectious Disease Journal. 2013;**32**:e348-e354. DOI:

[19] Rahimzadeh N, Otukesh H, Hoseini R, Shadani S, Hooman N. Serum procalcitonin level for prediction of high-grade vesicoureteral reflux in urinary tract infection. Iranian

[20] Barati L, Safaeian B, Mehrjerdian M, Vakili MA. Early prediction of renal parenchymal injury with serum procalcitonin. Journal of Renal Injury Prevention. 2016;**5**:108-111.

course of sepsis and MODS. Critical Care. 1999;**3**:45-50. DOI: 10.1186/cc306

DOI: 10.1097/INF.0b013e31815e4122

DOI: 10.1016/0140-6736(93)90277-N

DOI: 10.1210/jcem.79.6.7989463

10.1186/cc1843

PMID: 12107804

DOI: 10.1542/peds.114.2.e249

10.1097/INF.0b013e3182905d83

DOI: 10.15171/jrip.2016.23

Journal of Kidney Diseases. 2014;**8**:105-108

America. 2006;**53**:379-400. DOI: 10.1016/j.pcl.2006.02.011

2005;**20**:1445-1448. DOI: 10.1007/s00467-005-1941-6

Pediatrics. 2005;**115**:e706-e709. DOI: 10.1542/peds.2004-1631

## **Conflict of interest**

The author declares no conflict of interest in this work.
